Influence of perioperative blood glucose levels on outcome after infrainguinal bypass surgery in patients with diabetes

British Journal of Surgery

Volumn 93, Issue 11, 2006, Pages 1360-1367

  Malmstedt, J ^a   Wahlberg, E ^a   Jorneskog G ^b   Swedenborg, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

AMPUTATION; ARTICLE; BYPASS SURGERY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOOT ULCER; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GRAFT OCCLUSION; HUMAN; HYPERGLYCEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RISK FACTOR; SURGICAL WOUND;

AGED; AMPUTATION; ARTERIAL OCCLUSIVE DISEASES; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; HYPERGLYCEMIA; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; POSTOPERATIVE COMPLICATIONS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33750959020     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5466     Document Type: Article

References (44)

1. Feinglass J, Pearce WH, Martin GJ, Gibbs J, Cowper D, Sorensen et al. Postoperative and amputation-free survival outcomes after femorodistal bypass grafting surgery: findings from the Department of Veterans Affairs National Surgical Quality Improvement Program. J Vasc Surg 2001; 34: 283-290.
2. Goshima KR, Mills JL Sr, Hughes JD. A new look at outcomes after infrainguinal bypass surgery: traditional reporting standards systematically underestimate the expenditure of effort required to attain limb salvage. J Vasc Surg 2004; 39: 330-335.
3. Pomposelli FB, Kansal N, Hamdan AD, Belfield A, Sheahan M, Campbell DR et al. A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg 2003; 37: 307-315.
4. Panneton JM, Gloviczki P, Bower TC, Rhodes JM, Canton LG, Toomey BJ. Pedal bypass for limb salvage: impact of diabetes on long-term outcome. Ann Vasc Surg 2000; 14: 640-647.
5. Seeger JM, Pretus HA, Carlton LC, Flynn TC, Ozaki CK, Huber TS. Potential predictors of outcome in patients with tissue loss who undergo infrainguinal vein bypass grafting. J Vasc Surg 1999; 30: 427-435.
6. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003; 26: 510-513.
7. Casey J, Flinn WR, Yao JS, Fahey V, Pawlowski J, Bergan JJ. Correlation of immune and nutritional status with wound complications in patients undergoing vascular operations. Surgery 1983; 93: 822-827.
8. Richet HM, Chidiac C, Prat A, Pol A, David M, Maccario M et al. Analysis of risk factors for surgical wound infections following vascular surgery. Am J Med 1991; 91: 170S-172S.
9. Schwartz ME, Harrington EB, Schanzer H. Wound complications after in situ bypass. J Vasc Surg 1988; 7: 802-807.
10. Johnson JA, Cogbill TH, Strutt PJ, Gundersen AL. Wound complications after infrainguinal bypass. Classification, predisposing factors, and management. Arch Surg 1988; 123: 859-862.
11. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67: 352-360.
12. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999; 22: 1408-1414.
13. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997; 63: 356-361.
14. Thourani VH, Weintraub WS, Stein B, Gebhart SSP, Craver JM, Jones EL et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 1999; 67: 1045-1052.
15. Norhammar A, Malmberg K, Diderholm E, Lagerqvist B, Lindahl B, Ryden L et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 2004; 43: 585-591.
16. McAlister FA, Man J, Bistritz L, Amad H, Tandon P. Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes. Diabetes Care 2003; 26: 1518-1524.
17. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001; 22: 607-612.
18. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367.
19. Garber AJ, Moghissi ES, Bransome ED Jr, Clark NG, Clement S, Cobin RH et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 2004; 10: 77-82.
20. Inzucchi SE, Rosenstock J. Counterpoint: inpatient glucose management: a premature call to arms? Diabetes Care 2005; 28: 976-979.
21. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG et al. Management of diabetes and hyperglycaemia in hospitals. Diabetes Care 2004; 27: 553-591.
22. Pomposelli JJ, Baxter JK III, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998; 22: 77-81.
23. Vriesendorp TM, Morelis QJ, Devries JH, Legemate DA, Hoekstra JB. Early post-operative glucose levels are an independent risk factor for infection after peripheral vascular surgery. A retrospective study. Eur J Vasc Endovasc Surg 2004; 28: 520-525.
24. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Sarg 1997; 26: 517-538.
25. Tai MM. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 1994; 17: 152-154.
26. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. Wiley: New York, 1989.
27. Forrest KY, Becker DJ, Kuller LH, Wolfson SK, Orchard TJ. Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. Atherosclerosis 2000; 148: 159-169.
28. Kent KC, Bartek S, Kuntz KM, Anninos E, Skillman JJ. Prospective study of wound complications in continuous infrainguinal incisions after lower limb arterial reconstruction: incidence, risk factors, and cost. Surgery 1996; 119: 378-383.
29. Nicoloff AD, Taylor LM Jr, McLafferty RB, Moneta GL, Porter JM. Patient recovery after infrainguinal bypass grafting for limb salvage. J Vasc Surg 1998; 27: 256-263.
30. Nehler MR, Hiatt WR, Taylor LM Jr. Is revascularization and limb salvage always the best treatment for critical limb ischemia? J Vasc Surg 2003; 37: 704-708.
31. Wolever TM. Effect of blood sampling schedule and method of calculating the area under the curve on validity and precision of glycaemic index values. Br J Nutr 2004; 91: 295-301.
32. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003; 290: 2041-2047.
33. Sheahan MG, Hamdan AD, Veraldi JR, McArthur CS, Skillman JJ, Campbell DR et al. Lower extremity minor amputations: the roles of diabetes mellitus and timing of revascularization. J Vasc Surg 2005; 42: 476-480.
34. Kalra M, Gloviczki P, Bower TC, Panneton JM, Harmsen WS, Jenkins GD et al. Limb salvage after successful pedal bypass grafting is associated with improved long-term survival. J Vasc Surg 2001; 33: 6-16.
35. Doenst T, Wijeysundera D, Karkouti K, Zechner C, Maganti M, Rao V et al. Hyperglycaemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2005; 130: 1144-1150.
36. Estrada CA, Young JA, Nifong LW, Chitwood WR Jr. Outcomes and perioperative hyperglycaemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 2003; 75: 1392-1399.
37. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005; 28(Suppl 1): S4-S36.
38. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
39. Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf-Peeters C, Van den Berghe G. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 2005; 365: 53-59.
40. Yan SF, Ramasamy R, Naka Y, Schmidt AM. Glycation, inflammation, and rage: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 2003; 93: 1159-1169.
41. Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005; 115: 2277-2286.
42. Turina M, Fry DE, Polk HC Jr. Acute hyperglycaemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med 2005; 33: 1624-1633.
43. McManus LM, Bloodworth RC, Prihoda TJ, Blodgett JL, Pinckard RN. Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycaemia. J Leukoc Biol 2001; 70: 395-404.
44. Perner A, Nielsen SE, Rask-Madsen J. High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Med 2003; 29: 642-645.